D. Western Therapeutics Institute, Inc. (TYO:4576)

TYO:4576 Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,709	1,126	1,867	2,334	1,933
Cash & Short-Term Investments	1,709	1,126	1,867	2,334	1,933
Cash Growth	51.78%	-39.69%	-20.01%	20.75%	-16.25%
Receivables	94	125	117	170	101
Inventory	86	101	87	79	88
Other Current Assets	131	123	66	76	40
Total Current Assets	2,020	1,475	2,137	2,659	2,162
Property, Plant & Equipment	9	11	10	10	4
Long-Term Investments	137	138	138	162	129
Other Intangible Assets	2	44	86	124	166
Other Long-Term Assets	1	1	2	1	1
Total Assets	2,169	1,669	2,373	2,956	2,462
Current Portion of Long-Term Debt	99	19	9	120	129
Current Income Taxes Payable	66	99	173	75	51
Other Current Liabilities	38	14	12	16	13
Total Current Liabilities	203	132	194	211	193
Long-Term Debt	506	778	875	847	210
Other Long-Term Liabilities	26	26	25	27	25
Total Liabilities	735	936	1,094	1,085	428
Common Stock	697	1,203	831	714	573
Additional Paid-In Capital	1,280	3,261	2,889	2,772	2,631
Retained Earnings	-543	-3,732	-2,442	-1,629	-1,200
Comprehensive Income & Other	-	1	1	-1	2
Total Common Equity	1,434	733	1,279	1,856	2,006
Minority Interest	-	-	-	15	28
Shareholders' Equity	1,434	733	1,279	1,871	2,034
Total Liabilities & Equity	2,169	1,669	2,373	2,956	2,462
Total Debt	605	797	884	967	339
Net Cash (Debt)	1,104	329	983	1,367	1,594
Net Cash Growth	235.56%	-66.53%	-28.09%	-14.24%	-13.74%
Net Cash Per Share	23.03	9.37	30.93	46.12	54.34
Filing Date Shares Outstanding	54.25	45.28	32.13	31.32	29.36
Total Common Shares Outstanding	54.25	41.63	32.13	30.87	29.36
Working Capital	1,817	1,343	1,943	2,448	1,969
Book Value Per Share	26.43	17.61	39.81	60.12	68.33
Tangible Book Value	1,432	689	1,193	1,732	1,840
Tangible Book Value Per Share	26.40	16.55	37.13	56.10	62.67

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.